|Day Low/High||156.75 / 158.64|
|52 Wk Low/High||114.27 / 197.00|
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement with Aurobindo Pharma Ltd.
The stocks inexplicably fell even after they delivered good earnings.
Jim discusses the trade tariff deadline extension, Emerson Electric's earnings, last night's interview with Allergan CEO Brent Saunders, Goldman Sachs, 3M and more!
Jim Cramer makes the calls on Alibaba, First American, Coherent, Ionis Pharmacuetical, Skechers USA, Corning, Bank of Internet and more.
Debra Cafaro, chairman and CEO of Ventas, tells Jim Cramer about the company's investment in university research facilities.
Brent Saunders, chairman and CEO of Allergan, talks to Jim Cramer about the company's drug pipeline, and Botox.
Love the banks, then hate the banks. Love the industrials? Nope, they're out, too. Jim Cramer says it's ugly, but he would use the weakness in the upside surprises.
Stocks finished lower as Wall Street processes a mega-merger between Sprint and T-Mobile US and as Walmart says it will sell its supermarket business in the U.K.
Allergan's bottom is going to take more time.
The market is looking past the positive results as the commentary surrounding the breakup overshadowed the earnings.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Monday's trending stocks from the floor of the New York Stock Exchange.
We will make a small sale in LLY and use the proceeds and opportunity to scoop up more PEP.
U.S. stock futures are rising Monday, as Wall Street processes a mega-merger between Sprint and T-Mobile and as Walmart says it will sell its supermarket business in the U.K.
Jim Cramer says foolish traders believe a trade war will trigger a recession, but they're wrong. Fight the crosswinds with a game plan for next week.
The drugmakers and health insurer are preparing to unveil first-quarter numbers.
The Dublin drugmaker announced data from Achieve II, a clinical trial evaluating potential migraine treatment drug ubrogepant.
I think M&A activity will pick up markedly going forward across the industry.
Jim discusses earnings from Nucor and Danaher, recent headlines about Apple, Amazon, Allergan, and more!
I don't understand the fundamentals but I find the chart interesting.
How do you get a stock moving? Jim Cramer says the answer is to invest in technology.
Dan Browne, co-founder, president and CEO of Revance Therapeutics, tells Jim Cramer his company is developing an alternative to Botox.
Today, Jim discusses Raytheon, tensions in Syria, bank earnings, Kohl's, Nordstrom and more!
The markets bounced back on easing trade tensions and the banks kicked off first-quarter earnings season.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.